Tradjenta and Eye pruritus - a phase IV clinical study of FDA data

Summary:

Eye pruritus is reported as a side effect among people who take Tradjenta (linagliptin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Coumadin, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Eye pruritus when taking Tradjenta. It is created by eHealthMe based on reports of 9,889 people who have side effects when taking Tradjenta from the FDA, and is updated regularly.

What is Tradjenta?

Tradjenta has active ingredients of linagliptin. It is often used in diabetes. eHealthMe is studying from 9,987 Tradjenta users. Check the latest studies of Tradjenta.

What is Eye pruritus?

Eye pruritus (eye itching) is found to be associated with 1,000 drugs and 1,088 conditions by eHealthMe. Check the latest studies of Eye pruritus.

On Jul, 12, 2026

9,889 people reported to have side effects when taking Tradjenta.
Among them, 12 people (0.12%) have Eye pruritus.

Among these 12 people:

How long have people been on Tradjenta when they have Eye pruritus? *

What is the gender of people who have Eye pruritus when taking Tradjenta? *

female: 75 %
male: 25 %

What is the age of people who have Eye pruritus when taking Tradjenta? *

What are other drugs people take besides Tradjenta? *

What are other side effects people have besides Eye pruritus? *

Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Headache (pain in head): 2 people, 16.67%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 16.67%
Fatigue (feeling of tiredness): 2 people, 16.67%
Hyperhidrosis (abnormally increased sweating): 2 people, 16.67%
Eye Pain: 2 people, 16.67%
Eye Irritation: 2 people, 16.67%
Itching: 2 people, 16.67%
Joint Pain: 2 people, 16.67%
Migraine (headache): 2 people, 16.67%

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 16.67%
High Blood Cholesterol: 2 people, 16.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 8.33%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 8.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 8.33%
Breast Cancer Female: 1 person, 8.33%
Cardiac Disorder: 1 person, 8.33%
Cardiac Failure: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%
Dyslipidaemia (abnormal amount of lipids): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tradjenta and have Eye pruritus?

- Check whether Eye pruritus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tradjenta:

Tradjenta (9,987 reports)

Eye pruritus treatments and more:

Eye pruritus (33,977 reports)

Browse all side effects of Tradjenta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye pruritus:

Eye pruritus (1,000 drugs)

Browse all the conditions that are associated with Eye pruritus:

Eye pruritus (1,088 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on linagliptin (the active ingredients of Tradjenta) and Tradjenta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.